Damon Runyon Researchers

Meet Our Scientists
Gavin P. Dunn, MD, PhD

Glioblastoma remains the most aggressive brain tumor diagnosed in patients, and it is clear that new treatment strategies are needed. There is significant optimism around the use of approaches that stimulate a patient's immune system to treat brain tumors. Gavin focuses on identifying the specific components of a patient's brain tumor that the immune system recognizes and determining whether there are regional differences in this immune recognition. He hopes that this work will increase our understanding of how the immune system recognizes brain cancers and will increase our understanding of how to rationally design personalized vaccines to treat these tumors. 

Project title: "Characterizing the immunogenic landscapes of malignant brain tumors"
Institution: Washington University
Award Program: Clinical Investigator
Sponsor(s) / Mentor(s): John F. DiPersio, MD, PhD, and Robert D. Schreiber, PhD
Cancer Type: Brain
Research Area: Immunotherapy